Back to results
US 12,410,138 B2Granted
Process comprising the use of new iridium catalysts for enantioselective hydrogenation of 4-substituted 1,2-dihydroquinolines
AssigneeBayer Aktiengesellschaft
InventorsChristoph Schotes, Matthias Beller, Kathrin Junge, Weiping Liu, Jacob Schneekoenig, Thomas Leischner
Life of this patent
Estimating the term…
Abstract
New iridium catalysts for enantioselective hydrogenation of 4-substituted 1,2-dihydroquinolines The invention relates to a process for preparing optically active 4-substituted 1,2,3,4-tetra hydroquinolines (la, lb) comprising enantioselective hydrogenation of the corresponding 4-substituted 1,2-dihydroquinolines in presence of a chiral iridium (P,N)-ligand catalyst.
Claims14
A process for preparing a compound of formula (Ia) or (Ib),
- wherein
- R1 is selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy-C1-C6-alkyl, C3-C6-cycloalkyl, C6-C14-aryl, or C6-C14-aryl-C1-C4-alkyl,
- wherein the C1-C6-alkyl, C3-C6-cycloalkyl and the C1-C6-alkoxy in the C1-C6-alkoxy-C1-C6-alkyl moiety, are optionally substituted by 1 to 3 substituents independently selected from the group consisting of halogen, C1-C4-alkoxy, C1-C4-haloalkyl, C1-C4-haloalkoxy and phenyl, wherein the phenyl may be substituted by one to five substituents selected independently from each other from halogen, C1-C4-alkyl, C1-C4-alkoxy, C1-C4-haloalkyl, and C1-C4-haloalkoxy, and
- wherein the C6-C14-aryl and the C6-C14-aryl in the C6-C14-aryl-C1-C4-alkyl moiety in each case is unsubstituted or substituted by one to five substituents selected from the group consisting of halogen, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy and C1-C4-haloalkoxy,
- R2 and R3 are the same and are selected from the group consisting of hydrogen, C1-C6-alkyl, C1-C6-haloalkyl and C1-C6-alkoxy-C1-C6-alkyl,
- or
- R2 and R3 together with the carbon which they are bound to, form a C3-C6-cycloalkyl ring,
- R4 is hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkylamino, C2-C6-alkenyl, C2-C6-alkynyl, C3-C6-cycloalkyl, C3-C6-cycloalkyl-C1-C4-alkyl, C2-C6-alkenyloxy, 9-flurorenylmethyleneoxy, C6-C14-aryl, C6-C14-aryloxy, C6-C14-aryl-C1-C4-alkyloxy or C6-C14-aryl-C1-C4-alkyl,
- wherein the C6-C14-aryl as such or as part of a composite substituent is unsubstituted or substituted by one to five substituents selected from the group consisting of halogen, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy and C1-C4-haloalkoxy,
- n is 0, 1, 2, 3 or 4,
- each substituent R5, if present, is independently selected from the group consisting of halogen, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, hydroxyl, amino and —C(═O)—C1-C6-alkyl,
- the process comprising enantioselective hydrogenation of a compound of formula (II)
- wherein the substituents R1, R2, R3, R4, R5 and the integer n are each as defined for the compound of formula (Ia) or (Ib),
- in presence of a chiral iridium catalyst,
- wherein the chiral iridium catalyst is of the general formula (Va) or (Vb)
- wherein
- R6 is 2,6-diethyl-4-methylphenyl,
- R7 is hydrogen,
- R8 is methyl,
- R9 and R10 are both cyclohexyl,
- Y is a non-coordinating anion selected from the group consisting of [B(R18)4]− and [Al{OC(CF3)3}4]−of formula (VII),
- wherein R18 is 3,5-bis(trifluoromethyl)phenyl.
19 more elements
A chiral iridium catalyst selected from chiral iridium catalysts of general formulae (Va) and (Vb)
- wherein
- R6 is 2,6-diethyl-4-methylphenyl,
- R7 is hydrogen,
- R8 is methyl,
- R9 and R10 are both cyclohexyl,
- Y is a non-coordinating anion selected from the group consisting of [B(R18)4]− and [Al{OC(CF3)3}4]− of formula (VII),
- wherein R18 is 3,5-bis(trifluoromethyl)phenyl.
4 more elements
Dependencies are inferred from the claim text.